Overview
Philippe Gevaert practices in Gent, Belgium. Mr. Gevaert is rated as an Elite expert by MediFind in the treatment of Nasal Polyps. His top areas of expertise are Nasal Polyps, Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), Sinusitis, Allergic Rhinitis, and Endoscopy.
His clinical research consists of co-authoring 146 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 74 articles in the study of Nasal Polyps.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
- Nasal PolypsMr. Gevaert isElite. Learn about Nasal Polyps.
- SinusitisMr. Gevaert isElite. Learn about Sinusitis.
- Distinguished
- Allergic RhinitisMr. Gevaert isDistinguished. Learn about Allergic Rhinitis.
- AsthmaMr. Gevaert isDistinguished. Learn about Asthma.
- Advanced
- Nonallergic RhinopathyMr. Gevaert isAdvanced. Learn about Nonallergic Rhinopathy.
- Experienced
- AnaphylaxisMr. Gevaert isExperienced. Learn about Anaphylaxis.
- AnosmiaMr. Gevaert isExperienced. Learn about Anosmia.
- Atopic DermatitisMr. Gevaert isExperienced. Learn about Atopic Dermatitis.
- Chronic Obstructive Pulmonary Disease (COPD)
- Common ColdMr. Gevaert isExperienced. Learn about Common Cold.
- COVID-19Mr. Gevaert isExperienced. Learn about COVID-19.